TNGX Operating Cash Flow (Statement)
Tango Therapeutics Inc · Operating Cash Flow (Statement)
TNGX Operating Cash Flow (Statement)
Latest reported-$143.90Mperiod ending
TNGX Cash from Operations (-$24.80M → -$143.90M)
Annual operating cash flow (statement)
High-resolution chart · PNG
TNGX operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -138,886,000 | |
| -131,501,000 | |
| -117,982,000 | |
| -109,080,000 | |
| -59,527,000 | |
| 70,074,000 | |
| -24,803,000 |